Efficacy and Safety of Actonel ® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women
Condition: Postmenopausal Osteoporosis Interventions: Drug: Risedronate Sodium 35 MG [Actonel]; Drug: Calcium Vitamin D combination Sponsor: Dong-A ST Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2022 Category: Research Source Type: clinical trials
Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients
Conditions: Postmenopausal Osteoporosis; Hypovitaminosis D; Hyperparathyroidism Interventions: Drug: Risedronate; Drug: Vitamin D Sponsors: Hospital Regional 1o de Octubre; National Polytechnic Institute, Mexico; Universidad Nacional Autonoma de Mexico Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2022 Category: Research Source Type: clinical trials
